Editors' Picks
Prolor Biotech To Benefit From 'Bio-Better' Drug As Novo Nordisk Pulls Out by Nouvelle Asset Management
Israel
Prolor Biotech To Benefit From 'Bio-Better' Drug As Novo Nordisk Pulls Out by Nouvelle Asset Management
China
China Slowdown Is An Opportunity For Investors As The PRC Moves To Sustainable Growth by Lorin Cohen
Small-Cap Chinese Companies Fight Off American Distrust by Kevin Quon
Denmark
Novo Nordisk: Encouraging Pipeline News by Zacks Investment Research
Greece
ETF Tip Of The Week: Greece Goes Big by Wall Street Sector Selector
India
Earnings Analysis: Manpower by CapitalCube
Netherlands
Koninklijke Philips Electronics NV Management Discusses Q3 2012 Results - Earnings Call Transcript
Philippines
The iShares Philippines ETF: Tapping One Of The Last Bull Markets by Jaykumar Unni
Canada
Transglobe Energy Corp.: Aggressive Growth by Zacks Investment Research
This Fertilizer Stock Has Good Upside Potential by Efsinvestment
Canadian National Railway Management Discusses Q3 2012 Results - Earnings Call Transcript
2 Gold Stocks To Buy by Qineqt
Lions Gate Set For The Twilight Run by Josh Franklin
The CNOOC-Nexen Takeover Deal Is Now Less Likely To Happen by Felix Pinhasov
Enerplus: Strong Dividends Set To Continue by Efsinvestment
Lululemon: Why I Hope The Market Gives Me Another Chance To Short At $75 by Robert Broens
Why are you receiving this? You subscribed to Global Investing at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No comments:
Post a Comment